151 related articles for article (PubMed ID: 9039976)
1. Histopathologic features seen with different animal models following cutaneous sulfur mustard exposure.
Smith KJ; Casillas R; Graham J; Skelton HG; Stemler F; Hackley BE
J Dermatol Sci; 1997 Feb; 14(2):126-35. PubMed ID: 9039976
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous histopathologic features in weanling pigs after exposure to three different doses of liquid sulfur mustard.
Smith KJ; Skelton HG; Hobson DW; Reid FM; Blank JA; Hurst CG
Am J Dermatopathol; 1996 Oct; 18(5):515-20. PubMed ID: 8902098
[TBL] [Abstract][Full Text] [Related]
3. Reduction of erythema in hairless guinea pigs after cutaneous sulfur mustard vapor exposure by pretreatment with niacinamide, promethazine and indomethacin.
Yourick JJ; Dawson JS; Mitcheltree LW
J Appl Toxicol; 1995; 15(2):133-8. PubMed ID: 7782559
[TBL] [Abstract][Full Text] [Related]
4. Hairless guinea pig bioassay model for vesicant vapor exposures.
Mershon MM; Mitcheltree LW; Petrali JP; Braue EH; Wade JV
Fundam Appl Toxicol; 1990 Oct; 15(3):622-30. PubMed ID: 2258024
[TBL] [Abstract][Full Text] [Related]
5. Characterization of acute and long-term sulfur mustard-induced skin injuries in hairless guinea-pigs using non-invasive methods.
Dachir S; Cohen M; Fishbeine E; Sahar R; Brandies R; Horwitz V; Kadar T
Skin Res Technol; 2010 Feb; 16(1):114-24. PubMed ID: 20384890
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic approaches to dermatotoxicity by sulfur mustard. I. Modulaton of sulfur mustard-induced cutaneous injury in the mouse ear vesicant model.
Casillas RP; Kiser RC; Truxall JA; Singer AW; Shumaker SM; Niemuth NA; Ricketts KM; Mitcheltree LW; Castrejon LR; Blank JA
J Appl Toxicol; 2000 Dec; 20 Suppl 1():S145-51. PubMed ID: 11428628
[TBL] [Abstract][Full Text] [Related]
7. Histopathologic features seen in sulfur mustard induced cutaneous lesions in hairless guinea pigs.
Smith KJ; Graham JS; Moeller RB; Okerberg CV; Skelton H; Hurst CG
J Cutan Pathol; 1995 Jun; 22(3):260-8. PubMed ID: 7593821
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of 2,2'-dichlorodiethyl sulfide in hairless guinea pigs.
Yourick JJ; Dawson JS; Benton CD; Craig ME; Mitcheltree LW
Toxicology; 1993 Nov; 84(1-3):185-97. PubMed ID: 8266337
[TBL] [Abstract][Full Text] [Related]
9. Medical management of cutaneous sulfur mustard injuries.
Graham JS; Stevenson RS; Mitcheltree LW; Hamilton TA; Deckert RR; Lee RB; Schiavetta AM
Toxicology; 2009 Sep; 263(1):47-58. PubMed ID: 18762227
[TBL] [Abstract][Full Text] [Related]
10. Comparative morphology of sulfur mustard effects in the hairless guinea pig and a human skin equivalent.
Petrali JP; Oglesby SB; Hamilton TA; Mills KR
J Submicrosc Cytol Pathol; 1993 Jan; 25(1):113-8. PubMed ID: 8462065
[TBL] [Abstract][Full Text] [Related]
11. Model for assessing efficacy of topical skin protectants against sulfur mustard vapor using hairless guinea pigs.
Snider TH; Matthews MC; Braue EH
J Appl Toxicol; 1999 Dec; 19 Suppl 1():S55-8. PubMed ID: 10594902
[TBL] [Abstract][Full Text] [Related]
12. 2-Chloroethyl ethyl sulfide causes microvesication and inflammation-related histopathological changes in male hairless mouse skin.
Jain AK; Tewari-Singh N; Orlicky DJ; White CW; Agarwal R
Toxicology; 2011 Apr; 282(3):129-38. PubMed ID: 21295104
[TBL] [Abstract][Full Text] [Related]
13. CO2 laser debridement of sulphur mustard (bis-2-chloroethyl sulphide) induced cutaneous lesions accelerates production of a normal epidermis with elimination of cytological atypia.
Smith KJ; Skelton HG; Martin JL; Hurst CG; Hackley BE
Br J Dermatol; 1997 Oct; 137(4):590-4. PubMed ID: 9390337
[TBL] [Abstract][Full Text] [Related]
14. Topical iodine preparation as therapy against sulfur mustard-induced skin lesions.
Wormser U; Sintov A; Brodsky B; Nyska A
Toxicol Appl Pharmacol; 2000 Nov; 169(1):33-9. PubMed ID: 11076694
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory cytokine response in sulfur mustard-exposed mouse skin.
Ricketts KM; Santai CT; France JA; Graziosi AM; Doyel TD; Gazaway MY; Casillas RP
J Appl Toxicol; 2000 Dec; 20 Suppl 1():S73-6. PubMed ID: 11428647
[TBL] [Abstract][Full Text] [Related]
16. Acute and long-term transcriptional responses in sulfur mustard-exposed SKH-1 hairless mouse skin.
Vallet V; Poyot T; Cléry-Barraud C; Coulon D; Sentenac C; Peinnequin A; Boudry I
Cutan Ocul Toxicol; 2012 Mar; 31(1):38-47. PubMed ID: 21939433
[TBL] [Abstract][Full Text] [Related]
17. Time course of skin features and inflammatory biomarkers after liquid sulfur mustard exposure in SKH-1 hairless mice.
Mouret S; Wartelle J; Batal M; Emorine S; Bertoni M; Poyot T; Cléry-Barraud C; Bakdouri NE; Peinnequin A; Douki T; Boudry I
Toxicol Lett; 2015 Jan; 232(1):68-78. PubMed ID: 25275893
[TBL] [Abstract][Full Text] [Related]
18. Sulfur mustard-increased proteolysis following in vitro and in vivo exposures.
Cowan FM; Yourick JJ; Hurst CG; Broomfield CA; Smith WJ
Cell Biol Toxicol; 1993; 9(3):269-77. PubMed ID: 8299005
[TBL] [Abstract][Full Text] [Related]
19. Selection of non-steroidal anti-inflammatory drug and treatment regimen for sulfur mustard-induced cutaneous lesions.
Plahovinsak JL; Buccellato MA; Reid FM; Graham JS
Cutan Ocul Toxicol; 2016 Sep; 35(3):208-17. PubMed ID: 26362124
[TBL] [Abstract][Full Text] [Related]
20. Hematological profile of the euthymic hairless guinea pig following sulfur mustard vesicant exposure.
Gold MB; Scharf BA
J Appl Toxicol; 1995; 15(6):433-8. PubMed ID: 8603929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
